Philadelphia, PA, United States of America

Christopher Natale

This inventor holds 6 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: University of Pennsylvania, Linnaeus Therapeutics, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Natale. Retrieved from https://idiyas.com/inventor/christopher-natale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christopher Natale

Introduction: Christopher Natale, a talented inventor hailing from Philadelphia, PA, has made significant contributions to the world of technology and innovation.

Latest Patents: Christopher Natale holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over 20 years of experience in the industry, Christopher Natale has worked for top renewable energy companies, leading research and development teams to create cutting-edge solutions for a sustainable future.

Collaborations: Throughout his career, Christopher Natale has collaborated with renowned scientists and engineers from leading universities and research institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: Christopher Natale's passion for innovation and dedication to creating a greener world through his inventions make him a true pioneer in the field of renewable energy technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…